Back to search

Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors

Data up to Jan 2025

Published2003
Citations145
References27

Total Citations Per Year

Abstract

References (27)

The Mechanisms of Action of PPARs

2002 • 2,544 citations

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.

2000 • 1,536 citations

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

2000 • 1,159 citations

PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs

1999 • 1,091 citations

Differentiation and reversal of malignant changes in colon cancer through PPARγ

1998 • 984 citations

Terminal Differentiation of Human Breast Cancer through PPARγ

1998 • 844 citations

Angiosarcoma of skin and soft tissue: A study of forty-four cases

1981 • 546 citations

Angiosarcoma: A report of 67 patients and a review of the literature

1996 • 521 citations

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.

1993 • 473 citations

Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas

2002 • 416 citations

Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face

1999 • 387 citations

The contributions of cyclooxygenase-2 to tumor angiogenesis.

2000 • 363 citations

PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis

2002 • 352 citations

Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation.

2001 • 304 citations

PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis

2002 • 260 citations

Results of Two Consecutive Trials of Dose-Intensive Chemotherapy With Doxorubicin and Ifosfamide in Patients With Sarcomas

1998 • 197 citations

Pioglitazone Enhances Cytokine-Induced Apoptosis in Vascular Smooth Muscle Cells and Reduces Intimal Hyperplasia

2001 • 93 citations

Malignant vascular tumors in children and adolescents: A report from the Italian and German soft tissue sarcoma cooperative group

2002 • 91 citations

Antiangiogenic and Chemopreventive Activities of Celecoxib in Oral Carcinoma Cell

2002 • 62 citations

Approach to angiogenesis inhibition based on cyclooxygenase-2.

2002 • 55 citations

Angiosarcoma of the scalp: treatment with liposomal doxorubicin and radiotherapy

2001 • 47 citations

The antiangiogenic agents TNP-470 and 2-methoxyestradiol inhibit the growth of angiosarcoma in mice

1999 • 43 citations

Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma

1999 • 39 citations

Oral trofosfamide: an active drug in the treatment of soft-tissue sarcoma

1995 • 34 citations

Prognostic Factors and Survival in Late Adolescent and Adult Patients With Small Round Cell Tumors

2002 • 28 citations

Trofosfamide

1997 • 21 citations

Palliative Chemotherapy in Pretreated Patients with Advanced Cancer: Oral Trofosfamide Is Effective in Ovarian Carcinoma

2001 • 16 citations

Cited By (0)

Loading...
Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in… (2003) – Cancer | Metascience Observatory Explorer